CLRB (Cellectar Biosciences) Cyclically Adjusted Book per Share: $992.09 (As of Mar. 2026)


CLRB Cellectar Biosciences Inc CLRB
28 GF Score
Price $2.50
! 1 Warning Sign
View Full Analysis

What is Cellectar Biosciences Cyclically Adjusted Book per Share?

Cellectar Biosciences CLRB +1.20% 28 Cyclically Adjusted Book per Share is $992.09 as of Mar. 2026. GuruFocus rates CLRB with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cellectar Biosciences's adjusted book value per share for the three months ended in Mar. 2026 was $0.664. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $992.09 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cellectar Biosciences's average Cyclically Adjusted Book Growth Rate was -7.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -8.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cellectar Biosciences was -8.90% per year. The lowest was -23.40% per year. And the median was -12.10% per year.

As of today (2026-06-27), Cellectar Biosciences's current stock price is $2.501. Cellectar Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $992.09. Cellectar Biosciences's Cyclically Adjusted PB Ratio of today is 0.00.


Cellectar Biosciences  (NAS:CLRB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cellectar Biosciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.501/992.09
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cellectar Biosciences Cyclically Adjusted Book per Share Related Terms


Cellectar Biosciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Cellectar Biosciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellectar Biosciences Cyclically Adjusted Book per Share Chart

Cellectar Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,445.34 1,321.97 1,188.05 1,083.30 998.53

Cellectar Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,067.34 1,047.55 1,027.12 998.53 992.09

CLRB vs PTN, PLUR, VTGN: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Cellectar Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cellectar Biosciences Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellectar Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cellectar Biosciences's Cyclically Adjusted PB Ratio falls into.


CLRB
28GF Score
Cellectar Biosciences Inc CLRB
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellectar Biosciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cellectar Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.664/330.2130*330.2130
=0.664

Current CPI (Mar. 2026) = 330.2130.

Cellectar Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201606 4,914.500 241.018 6,733.239
201609 3,858.500 241.428 5,277.461
201612 4,225.000 241.432 5,778.645
201703 3,437.250 243.801 4,655.537
201706 2,716.250 244.955 3,661.656
201709 1,898.250 246.819 2,539.621
201712 1,626.333 246.524 2,178.434
201803 1,135.833 249.554 1,502.949
201806 784.500 251.989 1,028.029
201809 954.714 252.439 1,248.852
201812 670.938 251.233 881.860
201903 474.000 254.202 615.735
201906 478.613 256.143 617.016
201909 357.516 256.759 459.795
201912 255.194 256.974 327.926
202003 132.194 258.115 169.119
202006 221.612 257.797 283.864
202009 169.393 260.280 214.906
202012 230.192 260.474 291.823
202103 216.074 264.877 269.372
202106 192.092 271.696 233.464
202109 182.368 274.310 219.534
202112 155.211 278.802 183.832
202203 126.603 287.504 145.410
202206 92.216 296.311 102.767
202209 55.730 296.808 62.002
202212 26.048 296.797 28.981
202303 18.314 301.836 20.036
202306 -5.689 305.109 -6.157
202309 -44.517 307.789 -47.760
202312 -28.708 306.746 -30.904
202403 8.224 312.332 8.695
202406 3.797 314.175 3.991
202409 1.146 315.301 1.200
202412 8.967 315.605 9.382
202503 5.034 319.799 5.198
202506 3.071 322.561 3.144
202509 2.342 324.800 2.381
202512 1.891 324.054 1.927
202603 0.664 330.213 0.664

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $992.09 mean?
Cellectar Biosciences (CLRB) has a Cyclically Adjusted Book per Share of $992.09 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cellectar Biosciences and its competitors.
Is Cellectar Biosciences' Cyclically Adjusted Book per Share too high?
Cellectar Biosciences' current Cyclically Adjusted Book per Share is $992.09. Overall, Cellectar Biosciences has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Cellectar Biosciences' Cyclically Adjusted Book per Share compare to PTN and PLUR?
Cellectar Biosciences' Cyclically Adjusted Book per Share of $992.09 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cellectar Biosciences and its competitors. Cellectar Biosciences's current Cyclically Adjusted Book per Share is $992.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellectar Biosciences stock overvalued right now?
Cellectar Biosciences (CLRB) has a current Cyclically Adjusted Book per Share of $992.09. The current Cyclically Adjusted Book per Share is $992.09. Cellectar Biosciences' overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Cellectar Biosciences (CLRB), the current Cyclically Adjusted Book per Share is $992.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cellectar Biosciences Business Description

Address 100 Campus Drive, Florham Park, NJ, USA, 07932
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
28GF Score

Get the complete analysis for CLRB

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.50
Price